Infinitum Health Announces End of “COVID-Era” Pricing and Updates on Patented Product Line
- Infinitum Health Team

- Nov 10
- 2 min read


Phoenix, AZ — Infinitum Health, LLC, a biotechnology company dedicated to developing natural, evidence-based solutions for major health challenges, announced today the conclusion of its special “COVID” pricing program. During the pandemic, the company voluntarily reduced prices to make its core health products more accessible to customers worldwide.
With the conclusion of the program and the recent granting and pending approvals of key patents, Infinitum Health will be returning its products to standard pricing effective immediately.
ReLeaf™ — Now $29.99 (previously $21.99)
Infinimin® — Now $44.99 (previously $29.99)
Both products were originally introduced at these higher prices prior to the COVID-19 global health emergency and had been temporarily discounted to support community access during that period.
These adjustments reflect Infinitum Health’s continued investment in scientific innovation and the growing intellectual property portfolio surrounding its formulations.
U.S. Patent No. 12,364,725 B2 (issued July 22, 2025): Methods of Inhibiting Cancer Growth and Inhibiting Viral Infections — underlying technologies used in Infinimin®.
International Patent Application WO2024173433A2: Methods of Relieving Pain — pending patent covering the proprietary formulation in ReLeaf™.
“Infinitum Health was founded to push the boundaries of natural biotechnology,” said Kevin Engholdt, MS, MBA, Founder and CEO. “We’re deeply grateful to our customers who supported us during the pandemic. With our patents now secured and pending globally, we’re reinvesting in research, clinical partnerships, and product development — all aimed at making natural, scientifically validated healthcare accessible for the long term.”
Infinitum Health’s product line continues to focus on cancer, viral support, pain relief, skin health, and immune optimization, integrating biotechnology with traditional medicinal compounds.
For more information or to purchase products, visit www.infinitumhealth.com.




Comments